Authors: BROMIDGE SM DABBS S DAVIES DT DUCKWORTH DM FORBES IT HAM P JONES GE KING FD SAUNDERS DV STARR S THEWLIS KM WYMAN PA BLANEY FE NAYLOR CB BAILEY F BLACKBURN TP HOLLAND V KENNETT GA RILEY GJ WOOD MD

Citation: Sm. Bromidge et al., NOVEL AND SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS AS POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS, QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS, AND MOLECULAR MODELING OF SUBSTITUTED 1-(3-PYRIDYLCARBAMOYL)INDOLINES/, Journal of medicinal chemistry, 41(10), 1998, pp. 1598-1612

Authors: BROMIDGE SM BROWN F CASSIDY F CLARK MSG DABBS S HADLEY MS HAWKINS J LOUDON JM NAYLOR CB ORLEK BS RILEY GJ

Citation: Sm. Bromidge et al., DESIGN OF OXYIMINO)-1-AZABICYCLO[2.2.2]OCTANE-3-ACETONITRILE (SB-202026), A FUNCTIONALLY SELECTIVE AZABICYCLIC MUSCARINIC M1 AGONIST INCORPORATING THE N-METHOXY IMIDOYL NITRILE GROUP AS A NOVEL ESTER BIOISOSTERE()), Journal of medicinal chemistry, 40(26), 1997, pp. 4265-4280

Authors: BROMIDGE SM DUCKWORTH M FORBES IT HAM P KING FD THEWLIS KM BLANEY FE NAYLOR CB BLACKBURN TP KENNETT GA WOOD MD CLARKE SE

Citation: Sm. Bromidge et al., ETHYL-3-PYRIDYL)OXY]-5-PYRIDYL]CARBAMOYL]-INDOLINE (SB-242084) - THE FIRST SELECTIVE AND BRAIN PENETRANT 5-HT2C RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 40(22), 1997, pp. 3494-3496

Authors: FORBES IT DABBS S DUCKWORTH DM HAM P JONES GE KING FD SAUNDERS DV BLANEY FE NAYLOR CB BAXTER GS BLACKBURN TP KENNETT GA WOOD MD

Citation: It. Forbes et al., SYNTHESIS, BIOLOGICAL-ACTIVITY, AND MOLECULAR MODELING STUDIES OF SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS/, Journal of medicinal chemistry, 39(25), 1996, pp. 4966-4977

Authors: DEPRIEST SA MAYER D NAYLOR CB MARSHALL GR

Citation: Sa. Depriest et al., 3D-QSAR OF ANGIOTENSIN-CONVERTING ENZYME AND THERMOLYSIN INHIBITORS -A COMPARISON OF COMFA MODELS BASED ON DEDUCED AND EXPERIMENTALLY DETERMINED ACTIVE-SITE GEOMETRIES, Journal of the American Chemical Society, 115(13), 1993, pp. 5372-5384